Company News

Industry News

Company News

Industry News

01

2025-03

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel Structured Market Performance; AI in Healthcare Opens New Growth Opportunities

During the third week of February 2025, the pharmaceutical and biotechnology sector continued to exhibit structural divergence. Over the week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming both the CSI 300 Index and the Shanghai Composite Index, ranking ninth in terms of sector performance.

2025-03-01

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel Structured Market Performance; AI in Healthcare Opens New Growth Opportunities

01

2025-03

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

Recently, the pharmaceutical and biotechnology sector has exhibited a pronounced structural market trend, driven by the deep integration of AI technologies with healthcare applications, which is spurring industry-wide upgrades. At the same time, policy support for innovative drugs continues to strengthen, creating multiple favorable factors for the sector.

2025-03-01

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

01

2025-03

With the concerted support of 17 departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

Recently, the “Policy Measures for Coordinated Support from Relevant Provincial Departments for the Open and Innovative Development of the Biopharmaceutical Industry in the China (Jiangsu) Pilot Free Trade Zone” (hereinafter referred to as the “Policy Measures”) were officially released!

2025-03-01

With the concerted support of 17 departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

01

2025-03

Good News! Another Stem Cell Clinical Research Project Has Been Approved by the National Health Commission

Regenerative medicine technologies, exemplified by stem cell technology, represent the “third medical revolution” following pharmacological and surgical therapies. Stem cells possess the remarkable ability to differentiate into and form any type of tissue in vivo, as well as to self-renew and generate additional stem cells, making them a key frontier area of international medical research in recent years.

2025-03-01

Good News! Another Stem Cell Clinical Research Project Has Been Approved by the National Health Commission

01

2025-03

AI-Assisted Precise and Rapid Diagnosis of “Heart Conditions”

In recent years, Chinese enterprises have actively invested in research on the application of AI-powered medical imaging software in the field of cardiovascular diseases, resulting in the approval and launch of several products, primarily focused on niche areas such as coronary CT angiography and auxiliary analysis of electrocardiograms.

2025-03-01

AI-Assisted Precise and Rapid Diagnosis of “Heart Conditions”

01

2025-03

The drive for domestic substitution of high-end medical imaging equipment is unstoppable.

Medical imaging technology uses physical methods to acquire biological information, enabling the visualization of health status and serving as a core technology that drives the advancement of clinical disease early warning, diagnosis, and treatment.

2025-03-01

The drive for domestic substitution of high-end medical imaging equipment is unstoppable.
< 12 >

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home